Lutathera Approval Positions Novartis To Regain NET Share Taken By Ipsen

 
• By Eleanor Malone
Product life cycle
Lutathera approval may help Novartis manage Sandostatin's market decline • Source: Shutterstock

More from New Products

More from Scrip